CHRISTINA HELMS: Open Payments
NPI 1669776787 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,239 in 64 payments from 26 companies in 2025. Trend: 2023 $1,450 · 2024 $1,000 · 2025 $1,239
Food & beverage: $1,239
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $210 |
| AstraZeneca Pharmaceuticals LP | 4 | $185 |
| Novo Nordisk Inc | 7 | $110 |
| Lilly USA, LLC | 5 | $91 |
| Sumitomo Pharma America, Inc. | 4 | $83 |
| PFIZER INC. | 3 | $61 |
| GlaxoSmithKline, LLC. | 4 | $58 |
| Astellas Pharma US Inc | 3 | $50 |
| Amgen Inc. | 3 | $49 |
| Aimmune Therapeutics, Inc. | 2 | $43 |
Products named: AIRSUPRA, GEMTESA, Wegovy, MOUNJARO, PREVNAR 20, UBRELVY, CREON, Veozah.
Industry payments across OK — which companies pay providers there.
